Pierre Kyme insider trades

Open-market stock purchases and sales by Pierre Kyme, Chief Business Officer at Armata Pharmaceuticals, Inc, from SEC Form 4 filings since Feb 5, 2025.

Recent trades

DateStockTradeValue
Mar 14, 2026ARMP Armata Pharmaceuticals, IncSold (not open market)$10.9K
Mar 9, 2026ARMP Armata Pharmaceuticals, IncBought (not open market)—

Companies traded

  • ARMP Armata Pharmaceuticals, Inc: other filings, last Mar 14, 2026

Get free alerts when Pierre Kyme files a new trade →